Technology News and Research

RSS

Proposed legislation in Congress would improve U.S. global health R&D

Writing in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC Policy Officer Ashley Bennett describes the recently introduced "21st Century Global Health Technology Act, which would make several important and welcome changes to global health research and development programs" at USAID.

29 Apr 2013

DKT Ethiopia using GIS technology to improve family planning, HIV prevention programs

"In just six years, DKT Ethiopia has transformed its system for tracking contraceptive sales from pins and pencils to computers and satellites and, in the process, helped create a family planning and HIV prevention success story in the Horn of Africa," David Olson, a global development communications consultant, writes in the Huffington Post's "Global Motherhood" blog.

29 Apr 2013

MorphoSys initiates Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia patients

Xencor announced today that MorphoSys AG has dosed the first patient in a Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia.

29 Apr 2013

Researchers discover new insights into how cells make transition from nonmalignant to metastatic

Cancer cells that can break out of a tumor and invade other organs are more aggressive and nimble than nonmalignant cells, according to a new multi-institutional nationwide study.

29 Apr 2013

Medicaid expansion challenges: Which states are facing roadblocks, running out of time?

Twenty states and the District of Columbia have agreed to expand their Medicaid programs, to cover everyone under 133 percent of the federal poverty line. That leaves 30 states that haven't, although Avalere categorizes four states as leaning in that direction (Tennessee, Kentucky, Florida and New York). Some of these states have especially large uninsured populations.

29 Apr 2013

ACT announces European phase I clinical trial for Stargardt's disease using retinal pigment epithelial cells

Advanced Cell Technology, Inc. a leader in the field of regenerative medicine, today announced treatment of the first patient in the third dosage cohort, and seventh patient overall, in its European Phase I clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

26 Apr 2013

CNIO researcher captures panoramic photo of proteins that take part in human DNA replication

The Genomic Instability Group led by researcher -scar Fern-ndez-Capetillo at the Spanish National Cancer Research Centre (CNIO), has for the first time obtained a panoramic photo of the proteins that take part in human DNA division, a process known as replication.

26 Apr 2013

Biological imaging technologies create a new way to learn about cells

Researchers have married two biological imaging technologies, creating a new way to learn how good cells go bad. "Let's say you have a large population of cells," said Corey Neu, an assistant professor in Purdue University's Weldon School of Biomedical Engineering.

26 Apr 2013

Geisinger and Bucknell celebrates opening of Autism and Developmental Medicine Center

Officials from Geisinger Health System and Bucknell University celebrated the grand opening of the Autism and Developmental Medicine Center, a national model for implementing guidelines for early diagnosis, medication management and treatment options for children with developmental disorders.

26 Apr 2013

First Edition: April 26, 2013

Today's headlines include reports that some Democratic senators have concerns about the health law's roll out as well as other news about the measure's implementation.

26 Apr 2013

Scioderm completes Series A financing commitment totaling $16 million

Scioderm, a company developing novel dermatology therapeutics, today announced the completion of a Series A financing commitment totaling $16 million. Morgenthaler Ventures led the Series A financing, with Technology Partners as the second investor participating in the round.

26 Apr 2013

New device allows automatic suturing of large intestine during cancer colon surgery

The Spanish research centre Innotex has developed a device that enables automatic suturing of the large intestine after being sectioned during cancer colon surgery. The novelty of the system, called Insewing, is that it allows the use of absorbable suture material instead of metallic staples which are currently used and could cause intestinal stiffness and obstruction.

26 Apr 2013

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.

From Thermo Fisher Scientific Inc. 26 Apr 2013

New Haven Pharmaceuticals gets venture loan facility from Horizon Technology Finance

Horizon Technology Finance Corporation ("Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and clean-tech industries, today announced it has closed a $2 million venture loan facility with New Haven Pharmaceuticals, Inc. ("NHP"), a developer of prescription pharmaceuticals that utilize currently marketed drugs or active pharmaceutical ingredients generally recognized as safe for use in therapeutic applications.

26 Apr 2013

New research collaboration may help in developing TB vaccine for bovines and humans

Scientists at The University of Nottingham are studying whether harmful bacteria found in cattle could be harnessed to protect livestock from the devastating disease bovine tuberculosis (TB).

26 Apr 2013

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.

26 Apr 2013

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical trials of the medication within the next few months.

26 Apr 2013

Universal Health Services net revenues increase 2% to $1.83 billion in first quarter 2013

Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $119.8 million, or $1.21 per diluted share, during the first quarter of 2013 as compared to $128.6 million, or $1.31 per diluted share, during the comparable quarter of 2012.

26 Apr 2013

Norwegian researchers receive Fridtjof Nansen Award for pioneering work in memory research

The Fridtjof Nansen Award for excellence in science and medicine has been awarded to Norwegian University of Science and Technology Professors Edvard I. Moser and May-Britt Moser for pioneering work in memory research.

26 Apr 2013

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Using a one-of-a-kind computer-aided program, Mayo Clinic has developed and implemented a Mayo-wide electronic warning system to identify patients at risk of QT-related deaths from an abnormality in the heart's electrical system.

26 Apr 2013

Technology News and Research

Proposed legislation in Congress would improve U.S. global health R&D

DKT Ethiopia using GIS technology to improve family planning, HIV prevention programs

MorphoSys initiates Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia patients

Researchers discover new insights into how cells make transition from nonmalignant to metastatic

Medicaid expansion challenges: Which states are facing roadblocks, running out of time?

ACT announces European phase I clinical trial for Stargardt's disease using retinal pigment epithelial cells

CNIO researcher captures panoramic photo of proteins that take part in human DNA replication

Biological imaging technologies create a new way to learn about cells

Geisinger and Bucknell celebrates opening of Autism and Developmental Medicine Center

First Edition: April 26, 2013

Scioderm completes Series A financing commitment totaling $16 million

New device allows automatic suturing of large intestine during cancer colon surgery

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

New Haven Pharmaceuticals gets venture loan facility from Horizon Technology Finance

New research collaboration may help in developing TB vaccine for bovines and humans

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Universal Health Services net revenues increase 2% to $1.83 billion in first quarter 2013

Norwegian researchers receive Fridtjof Nansen Award for pioneering work in memory research

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News